BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33253272)

  • 1. Clinicopathological significance of core 3 O-glycan synthetic enzyme, β1,3-N-acetylglucosaminyltransferase 6 in pancreatic ductal adenocarcinoma.
    Doi N; Ino Y; Angata K; Shimada K; Narimatsu H; Hiraoka N
    PLoS One; 2020; 15(11):e0242851. PubMed ID: 33253272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-peptide beta1,3-N-acetylglucosaminyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans.
    Iwai T; Inaba N; Naundorf A; Zhang Y; Gotoh M; Iwasaki H; Kudo T; Togayachi A; Ishizuka Y; Nakanishi H; Narimatsu H
    J Biol Chem; 2002 Apr; 277(15):12802-9. PubMed ID: 11821425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells.
    Iwai T; Kudo T; Kawamoto R; Kubota T; Togayachi A; Hiruma T; Okada T; Kawamoto T; Morozumi K; Narimatsu H
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4572-7. PubMed ID: 15755813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
    Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
    Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancer.
    Ishida H; Togayachi A; Sakai T; Iwai T; Hiruma T; Sato T; Okubo R; Inaba N; Kudo T; Gotoh M; Shoda J; Tanaka N; Narimatsu H
    FEBS Lett; 2005 Jan; 579(1):71-8. PubMed ID: 15620693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.
    Remmers N; Anderson JM; Linde EM; DiMaio DJ; Lazenby AJ; Wandall HH; Mandel U; Clausen H; Yu F; Hollingsworth MA
    Clin Cancer Res; 2013 Apr; 19(8):1981-93. PubMed ID: 23446997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues.
    Balmaña M; Duran A; Gomes C; Llop E; López-Martos R; Ortiz MR; Barrabés S; Reis CA; Peracaula R
    Int J Biol Macromol; 2018 Jun; 112():33-45. PubMed ID: 29408556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas.
    St Hill CA; Farooqui M; Mitcheltree G; Gulbahce HE; Jessurun J; Cao Q; Walcheck B
    BMC Cancer; 2009 Mar; 9():79. PubMed ID: 19267921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
    Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
    Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycan motif profiling reveals plasma sialyl-lewis x elevations in pancreatic cancers that are negative for sialyl-lewis A.
    Tang H; Singh S; Partyka K; Kletter D; Hsueh P; Yadav J; Ensink E; Bern M; Hostetter G; Hartman D; Huang Y; Brand RE; Haab BB
    Mol Cell Proteomics; 2015 May; 14(5):1323-33. PubMed ID: 25733690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas.
    Kim GE; Bae HI; Park HU; Kuan SF; Crawley SC; Ho JJ; Kim YS
    Gastroenterology; 2002 Oct; 123(4):1052-60. PubMed ID: 12360467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.
    Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J
    Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of beta1,3-N-acetylglucosaminyltransferase-2 (beta3Gn-T2) by beta3Gn-T8. Possible involvement of beta3Gn-T8 in increasing poly-N-acetyllactosamine chains in differentiated HL-60 cells.
    Seko A; Yamashita K
    J Biol Chem; 2008 Nov; 283(48):33094-100. PubMed ID: 18826941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manganese ion concentration affects production of human core 3 O-glycan in Saccharomyces cerevisiae.
    Saito F; Sakamoto I; Kanatani A; Chiba Y
    Biochim Biophys Acta; 2016 Sep; 1860(9):1809-20. PubMed ID: 27259834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma.
    Yuan Y; Yang Z; Miao X; Li D; Liu Z; Zou Q
    Tumour Biol; 2015 Dec; 36(12):9961-8. PubMed ID: 26178481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta1,3-N-Acetylglucosaminyltransferase-7 (beta3Gn-T7) acts efficiently on keratan sulfate-related glycans.
    Seko A; Yamashita K
    FEBS Lett; 2004 Jan; 556(1-3):216-20. PubMed ID: 14706853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core O-glycans required for lymphocyte homing gene knockout mice of core 1 beta1,3-N-acetylglucosaminyltransferase and core 2 N-acetylglucosaminyltransferase.
    Mitoma J; Fukuda M
    Methods Enzymol; 2010; 479():257-70. PubMed ID: 20816171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity status of D9S105 marker is associated with downregulation of Krüppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions.
    Funel N; Morelli M; Giovannetti E; Del Chiaro M; Pollina LE; Mosca F; Boggi U; Cavazzana A; Campani D
    Pancreatology; 2011; 11(1):30-42. PubMed ID: 21412023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO blood group IgM isoagglutinins interact with tumor-associated O-glycan structures in pancreatic cancer.
    Hofmann BT; Stehr A; Dohrmann T; Güngör C; Herich L; Hiller J; Harder S; Ewald F; Gebauer F; Tachezy M; Precht C; Izbicki JR; Bockhorn M; Wagener C; Wolters-Eisfeld G
    Clin Cancer Res; 2014 Dec; 20(23):6117-26. PubMed ID: 25320359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structural analysis of glycans expressed within tumors derived from pancreatic cancer patient-derived xenograft mouse models.
    Hasehira K; Furuta T; Shimomura O; Asada M; Oda T; Tateno H
    Biochem Biophys Res Commun; 2021 Jan; 534():310-316. PubMed ID: 33288196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.